Following a major acquisition, Research Capital analyst Andre Uddin has raised his price target on Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:CPH). The analyst summarized the development. “This morning, Cipher made an accretive acquisition of two dermatology products from ParaPRO LLC (private) for US$89.5M – CPH paid US$80 million in cash […]
With catalysts on the horizon, Raymond James analyst Rahul Sarugaser has upped his rating and price target on Alpha Cognition (Alpha Cognition Stock Quote, Chart, News, Analysts, Financials CSE:ACOG). In a research update to clients July 15, the analyst raised his rating on ACOG from “Market Perform 3” to “Outperform 2”, while hiking his price […]
Share
Tweet
Share
